Trial Profile
Monocentric, prospective, randomized placebo-controlled double-blind phase II trial exploring protective effects of Ginkgo biloba special extract EGb 761® against noise-induced temporary hearing impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Noise-induced hearing loss
- Focus Therapeutic Use
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 10 Oct 2016 Status changed from active, no longer recruiting to completed.
- 15 Oct 2013 New trial record